AI Article Synopsis

  • Carcinoid heart disease primarily affects the right side of the heart and is associated with rare solid metastases from carcinoid tumors.
  • A combination of imaging techniques is essential for accurate diagnosis and localization of carcinoid disease, with biopsy being the definitive method for confirmation.
  • In a specific case, an indium-111 octreotide scan showed tumor uptake in the colon, liver, and right ventricle, but biopsy results indicated both hepatic carcinoid and cardiac myxoma, highlighting the complexity of diagnosing carcinoid disease.

Article Abstract

Carcinoid heart disease is classically described as right-sided valvular pathology. Solid cardiac metastases from carcinoid tumors are seldom reported. A multimodality imaging approach is needed to diagnose and localize this disease. Biopsy remains the gold standard to confirm the diagnosis of carcinoid. Octreotide uptake is characteristic of carcinoid tumor but not myxoma; thus, an indium-111 octreotide scan is very specific for the diagnosis of carcinoid tumor and helps in assessing the extent of carcinoid disease. We present a case in which an indium-111 octreotide scan revealed uptake in three distinct masses in the colon, liver, and right ventricle. The results of the scan were contradictory to the biopsy results, which were diagnostic for hepatic carcinoid and cardiac myxoma.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677865PMC
http://dx.doi.org/10.1080/08998280.2016.11929369DOI Listing

Publication Analysis

Top Keywords

indium-111 octreotide
12
carcinoid
8
diagnosis carcinoid
8
carcinoid tumor
8
octreotide scan
8
utility indium-111
4
octreotide
4
octreotide identify
4
identify cardiac
4
cardiac metastasis
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!